Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

Publisher: Karger

E-ISSN: 1423-0232|68|4-6|326-332

ISSN: 0030-2414

Source: Oncology, Vol.68, Iss.4-6, 2005-08, pp. : 326-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content